Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q1 2026 Earnings Call Transcript April 29, 2026
Agios Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-1.69, expectations were $-1.81.
Operator: Good day, and thank you for standing by. Welcome to the First Quarter 2026 Agios Financial Results and Business Highlights. [Operator Instructions] Please be advised that today’s call is being recorded. I would now like to hand it over to our first speaker, Morgan Sanford, Head of...
